ANVISA registration 10071770899ActiveRESPIRATORY SYNCYTIAL VIRUS (RSV)
ANVISA Registration Number: 10071770899ABBOTT DIAGNOSTICOS RAPIDOS S.A.ABBOTT DIAGNOSTICS SCARBOROUGH, INCRisk Class II
Device names
- Technical name
- RESPIRATORY SYNCYTIAL VIRUS (RSV)
- Risk class
- Class II
PT: VÍRUS SINCICIAL RESPIRATÓRIO (VSR)
Registration details
- Registration Number
- 10071770899
- Process Number
- 25351661693201971
- CNPJ
- 50248780000161
Company information
- Registration Holder
- ABBOTT DIAGNOSTICOS RAPIDOS S.A.
- Manufacturer
- ABBOTT DIAGNOSTICS SCARBOROUGH, INC
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Feb 17, 2020
- Validity
- VIGENTE
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for RESPIRATORY SYNCYTIAL VIRUS (RSV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10071770899 and manufactured by ABBOTT DIAGNOSTICS SCARBOROUGH, INC. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.